Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010:2010:831901.
doi: 10.1155/2010/831901. Epub 2010 Feb 9.

Long-term effects of metformin and lifestyle modification on nonalcoholic Fatty liver disease obese adolescents

Lian Tock  1 , Ana R Dâmaso, Aline de Piano, June Carnier, Priscila L Sanches, Henrique Manoel Lederman, Regina M Y Ernandes, Marco Túlio de Mello, Sérgio Tufik
Affiliations

Long-term effects of metformin and lifestyle modification on nonalcoholic Fatty liver disease obese adolescents

Lian Tock et al. J Obes. 2010.

Abstract

Objective. To assess the long-term effects of metformin in combination with lifestyle intervention and its association between insulin levels and the degree of steatosis at ultrasonography (US) in obese adolescents. Methods. Thirty-five postpubertal obese boys were randomized into two groups: one receiving metformin in combination with a multidisciplinary lifestyle intervention versus a placebo group, which also received the same intervention. The visceral, subcutaneous fat and degree of steatosis were measured by ultrasonography. Fasting blood samples were collected to analyze glucose, insulin, insulin resistance, and aminotransferases. Repeated ANOVA measures were used to compare changes over time and between groups, and Spearman's correlations were used to identify an association between insulin and the degree of steatosis at US. Results. There was a positive correlation between the degree of steatosis at US with insulin concentrations and HOMA-IR. Long-term therapy plus metformin significantly reduced body weight, body mass index, insulin, HOMA-IR, and visceral fat. Conclusions. Metformin was more effective than the placebo in improving clinical parameters associated with obesity and steatosis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Correlation between degree of steatosis at US and Insulin levels at baseline conditions of adolescent obese boys.
Figure 2
Figure 2
Correlation between degree of steatosis at US and HOMA-IR at baseline conditions of adolescent obese boys.
See this image and copyright information in PMC

References

    1. Machado M, Cortez-Pinto H. Non-alcoholic fatty liver disease and insulin resistance. European Journal of Gastroenterology and Hepatology. 2005;17(8):823–826. - PubMed
    1. Tock L, Prado WL, Caranti DA, et al. Nonalcoholic fatty liver disease decrease in obese adolescents after multidisciplinary therapy. European Journal of Gastroenterology and Hepatology. 2006;18(12):1241–1245. - PubMed
    1. Bugianesi E, Gentilcore E, Manini R, et al. A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease. American Journal of Gastroenterology. 2005;100(5):1082–1090. - PubMed
    1. Dâmaso AR, do Prado WL, de Piano A, et al. Relationship between nonalcoholic fatty liver disease prevalence and visceral fat in obese adolescents. Digestive and Liver Disease. 2008;40(2):132–139. - PubMed
    1. van der Poorten D, Milner K-L, Hui J, et al. Visceral fat: a key mediator of steatohepatitis in metabolic liver disease. Hepatology. 2008;48(2):449–457. - PubMed

LinkOut - more resources